1. Home
  2. MSGE vs ARQT Comparison

MSGE vs ARQT Comparison

Compare MSGE & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madison Square Garden Entertainment Corp.

MSGE

Madison Square Garden Entertainment Corp.

HOLD

Current Price

$74.24

Market Cap

3.0B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$27.74

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGE
ARQT
Founded
2020
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
MSGE
ARQT
Price
$74.24
$27.74
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$61.00
$34.00
AVG Volume (30 Days)
576.8K
1.9M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
1.59
N/A
Revenue
$942,734,000.00
$376,072,000.00
Revenue This Year
$10.53
$34.85
Revenue Next Year
$6.53
$29.39
P/E Ratio
$46.91
N/A
Revenue Growth
N/A
91.34
52 Week Low
$35.31
$13.70
52 Week High
$82.79
$31.77

Technical Indicators

Market Signals
Indicator
MSGE
ARQT
Relative Strength Index (RSI) 46.21 62.27
Support Level $68.93 $22.09
Resistance Level $82.79 $28.80
Average True Range (ATR) 2.64 1.24
MACD -0.81 0.07
Stochastic Oscillator 10.58 51.09

Price Performance

Historical Comparison
MSGE
ARQT

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: